natgillin/translations-raw huggingface dataset:
Ciprofloxacin Bayer 250 mg oral suspension i enkeltdosisposer er indiceret til behandling af følgende infektioner (se pkt. 
The Ciprofloxacin Bayer 250 mg oral suspension in single-dose sachets are indicated for the treatment of the following infections (see sections 4.4 and 5.1).
Hæmolytisk anæmi 
Haemolytic anaemia Agranulocyt osis
Bacillus anthracis 
Inhalational anthrax
Ikke almindelige bivirkninger (forekommer hos mellem 1 og 10 af hver 1000 personer): 
Uncommon side effects (between 1 and 10 in every 1,000 people are likely to get these):
• urinvejsinfektioner 
• Urinary tract infections
CIPROXIN 250 mg/5ml suspension oral anvendelse 
CIPROXIN 250 mg/5 ml oral suspension oral use
Neutropeni Leukocytose Trombocytopeni Trombocytæmi 
Thrombocytopenia Thrombocytaemia
En måleske (ca. 5,0 ml suspension) indeholder ca. 250 mg ciprofloxacin. 
1 measuring spoonful (approx 5.0 mL suspension) provides approx. 250 mg ciprofloxacin.
• udsættelse for indånding af miltbrandbakterier Ciprofloxacin Bayer kan også anvendes til behandling af andre specielle, alvorlige infektioner hos børn og unge efter et lægeligt skøn. 
• Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.
CIPROXIN 500 mg/5ml suspension oral anvendelse 
CIPROXIN 500 mg/5 ml oral suspension oral use
Hos unge og prænatale dyr, som var udsat for quinoloner, er der set effekt på umodent bindevæv. 
In juvenile and prenatal animals exposed to quinolones, effects on immature cartilage have been observed, thus, it cannot be excluded that the drug could cause damage to articular cartilage in the human immature organism / foetus (see section
- små punktformede blødninger under huden (petekkier), forskellige hududbrud eller udslæt (f.eks. det potentielt dødelige Stevens-Johnson syndrom eller toksisk epidermal nekrolyse) - muskelsvaghed, betændelse i en sene (inflammation), senebrud - især i den store sene på bagsiden af anklen (akillessenen) (se pkt. 
- small, pin-point bleeding under the skin (petechiae); various skin eruptions or rashes (for example, the potentially fatal Stevens-Johnson syndrome or toxic epidermal necrolysis) - muscle weakness, tendon inflammation, tendon rupture - especially of the large tendon at the back of the ankle (Achilles tendon) (see Section 2: Take special care with Ciprofloxacin Bayer); worsening of the symptoms of myasthenia gravis (see Section 2: Take special care with Ciprofloxacin Bayer)
LÆGEMIDDELFORM Oral suspension (i enkeltdosisposer). 
500 mg oral suspension (in single dose sachets)
4.4) Exacerbation af symptomer på myasthenia gravis (se pkt. 
Muscular weakness Tendinitis Tendon rupture (predominan tly Achilles tendon) (see section 4.4) Exacerbation of symptoms of myasthenia gravis (see section 4.4)
CIPROBAY 750 mg filmovertrukne tabletter oral anvendelse 
CIPROBAY 750 mg film-coated tablets oral use
- tarmbetændelse (colitis) relateret til brug af antibiotika (kan i sjældne tilfælde være dødelig) (se pkt 2 Vær ekstra forsigtig med at tage Ciprofloxacin Bayer) - ændringer i blodtal (leukopeni, leukocytose, neutropeni, anæmi), øget eller nedsat mængde af en bestemt blodstørkningsfaktor (trombocytter) - allergisk reaktion, hævelser (ødemer) eller hurtig hævelse i hud og slimhinder (angioødem) - øget blodsukker (hyperglykæmi) - forvirring, desorientering, angst, mærkelige drømme, depression eller hallucinationer - stikken og prikken, usædvanlig følsomhed over for sanseindtryk, nedsat hudfølsomhed, rysten, 
- inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in rare cases) (see Section 2: Take special care with Ciprofloxacin Bayer) - changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), a drop in the number of red and white blood cells and platelets (pancytopenia), which may be fatal, bonemarrow depression which may also be fatal (see Section 2: Take special care with Ciprofloxacin Bayer) - allergic reaction, allergic swelling (oedema), rapid swelling of the skin and mucous membranes (angiooedema), severe allergic reaction (anaphylactic shock) which can be life-threatening (see Section 2: Take special care with Ciprofloxacin Bayer) - increased blood sugar (hyperglycemia) - anxiety reaction, strange dreams, depression, mental disturbances (psychotic reactions) (see Section 2: Take special care with Ciprofloxacin Bayer) - decreased skin sensitivity, tremor, migraine, disorder of sense of smell (olfactory disorders) - tinnitus, impaired hearing - fainting, inflammation of the blood vessel (vasculitis) - shortness of breath including asthmatic symptoms - pancreatitis
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder 1 flaske med 400 mg / 200 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 400 mg /200 mL solution for infusion)
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder 5 pakninger med flasker, hver med 200 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 boxes with bottles of 200 mL solution for infusion)
10 mg/kg to gange dagligt op til 15 mg/kg legemsvægt to gange dagligt, maksimalt 400 mg pr. dosis. 
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 400 mg per dose.
10 mg/kg op til 15 mg/kg legemsvægt to gange dagligt, maksimalt 500 mg pr. dosis. 
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose.
Vær ekstra forsigtig med at tage Ciprofloxacin Bayer 
Take special care with Ciprofloxacin Bayer
Ciprofloxacin Bayer 500 mg oral suspension i enkeltdosisposer er indiceret til behandling af følgende infektioner (se pkt. 
The Ciprofloxacin Bayer 500 mg oral suspension in single-dose sachets are indicated for the treatment of the following infections (see sections 4.4 and 5.1).
Med mindre ciprofloxacinresistente Neisseria gonorhoeae kan udelukkes, bør ciprofloxacin gives sammen med et andet passende antibakterielt lægemiddel. 
Ciprofloxacin should be co-administered with another appropriate antibacterial agent unless ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded.
CIPROXIN 750 mg filmovertrukne tabletter oral anvendelse 
CIPROXIN 750 mg film-coated tablets oral use
[mg] 
(pyelonephritis)
Ciprobay XR 1000 mg tabletter med modificeret udløsning oral anvendelse 
Ciprobay XR 1000 mg modified release tablets oral use
Ciprofloxacin Bayer 400 mg/200 ml infusionsvæske, opløsning er indiceret til behandling af følgende infektioner (se pkt. 
Ciprofloxacin Bayer 400 mg/200 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1).
5 g/100 ml suspension oral anvendelse 
5 g/100 ml oral suspension oral use
Indehaveren af markedsføringstilladelsen og fremstiller [Se bilag I - Udfyldes nationalt] {Navn og adresse} <{Tlf}> <{Fax}> <{Email}> 
Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally] {Name and address} <{tel}> <{fax}> <{e-mail}>
CIPROBAY 250 mg filmovertrukne tabletter oral anvendelse 
CIPROBAY 250 mg film-coated tablets oral use
½ måleske (ca. 2,5 ml suspension) indeholder ca. 250 mg ciprofloxacin. 
½ measuring spoonful (approx 2.5 mL suspension) provides approx. 250 mg ciprofloxacin.
10 mg/kg op til 20 mg/kg legemsvægt to gange dagligt, maksimalt 750 mg pr. dosis. 
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose.
Bayer HealthCare AG D-513 68 Leverkusen Tyskland 
Bayer HealthCare AG D-513 68 Leverkusen Germany
Ciprofloxacin Bayer og tilhørende navne (se bilag I) 250 mg oral suspension i enkeltdosisposer [Se bilag I - Udfyldes nationalt] 
Ciprofloxacin Bayer and associated names (see Annex I) 250 mg oral suspension in single-dose sachets [See Annex I - To be completed nationally]
Dette gælder især, hvis standardbehandlingen har svigtet, eller der er bakteriel resistens, hvor de mikrobiologiske data berettiger anvendelsen af ciprofloxacin. 
Nevertheless, in very rare instances, after microbiological documentation of the causative organism and evaluation of the risk/benefit balance, ciprofloxacin may be prescribed to these patients for the treatment of certain severe infections, particularly in the event of failure of the standard therapy or bacterial resistance, where the microbiological data may justify the use of ciprofloxacin.
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder 1 flaske med 100 mg / 50 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 100 mg / 50 mL solution for infusion)
Der blev ikke fremsat forslag om harmonisering af det produktresumé, der gælder for tabletformuleringen med modificeret udløsning. 
Regarding the modified release tablet SPC, no proposal for a harmonised SPC was provided.
- tarmbetændelse (colitis) relateret til brug af antibiotika (kan i sjældne tilfælde være dødelig) (se pkt 2 Vær ekstra forsigtig med at tage Ciprofloxacin Bayer) - ændringer i blodtal (leukopeni, leukocytose, neutropeni, anæmi), øget eller nedsat mængde af en bestemt blodstørkningsfaktor (trombocytter) - allergisk reaktion, hævelser (ødemer) eller hurtig hævelse i hud og slimhinder (angioødem) 
- inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) (see Section 2: Take special care with Ciprofloxacin Bayer) - changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), increased or decreased amounts of a blood clotting factor (thrombocytes)
CIPROXIN 250 mg filmovertrukne tabletter oral anvendelse 
CIPROXIN 250 mg film-coated tablets oral use
Kort fortalt anbefaledes et behandlingsregime på 500 mg ciprofloxacin 2 gange dagligt til forebyggende behandling hos neutropeniske patienter. 
In summary, for prophylaxis in neutropenic patients, a 500 mg bid ciprofloxacin dosage regimen was recommended.
5 ml to gange dagligt op til 7,5 ml to gange dagligt (én 5 ml måleske to gange dagligt op til halvanden 5 ml måleske to gange dagligt) 
5 mL twice daily to 7.5 mL twice daily (one 5-mL measuring spoonful twice daily up to one and a half 5mL measuring spoonfuls twice daily)
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder 5 pakninger med flasker, hver med 50 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 5 boxes with bottles of 50 mL solution for infusion)
CIPROBAY 500 mg filmovertrukne tabletter oral anvendelse 
CIPROBAY 500 mg film-coated tablets oral use
15 ml to gange dagligt (tre 5 ml måleskeer to gange dagligt) 
15 mL twice daily (three 5-mL measuring spoonfuls twice daily)
SÅDAN BRUGES CIPROFLOXACIN BAYER 
HOW TO USE CIPROFLOXACIN BAYER
Behandlingsvarighed (inklusiv evt. initial parenteral behandling med ciprofloxacin) Hos præ-menopausale kvinder kan der gives 500 mg som éngangsdosis svarende til 10 ml éngangsdosis = to 5 ml måleskeer som éngangsdosis 
In pre-menopausal women, 500 mg single dose may be used corresponding to 10 mL single dose = two 5-mL measuring spoonfuls as a single dose
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder beskyttelsesposer med poser med hver med 100 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 100 mL solution for infusion)
En måleske (ca. 5,0 ml suspension) indeholder ca. 5000 mg ciprofloxacin. 
1 measuring spoonful (approx 5.0 mL suspension) provides approx. 500 mg ciprofloxacin.
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder 1 flaske med 200 mg / 100 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing 1 bottle of 200 mg / 100 mL solution for infusion)
10g/100 ml suspension oral anvendelse 
10 g/100 ml oral suspension oral use
Ciprofloxacin Bayer og tilhørende navne (se bilag I) 500 mg oral suspension i enkeltdosisposer [Se bilag I - Udfyldes nationalt] 
Ciprofloxacin Bayer and associated names (see Annex I) 500 mg oral suspension in single-dose sachets [See Annex I - To be completed nationally]
Ciprofloxacin Bayer 100 mg/50 ml infusionsvæske, opløsning er indiceret til behandling af følgende infektioner (se pkt. 
Ciprofloxacin Bayer 100 mg/50 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1).
Glucosebelastning 
Glucose Load
Inhalationsanthrax, profylakse efter eksponering og kurativ behandling til patienter, som har behov for parenteral behandling. 
Inhalation anthrax post-exposure prophylaxis and curative treatment for persons requiring parenteral treatment Drug administration should begin as soon
10 mg/kg op til 20 mg/kg legemsvægt to gange dagligt, maksimalt 750 mg pr. dosis, svarende til 0,1 ml/kg legemsvægt to gange dagligt til 0,2 ml/kg legemsvægt to gange dagligt, maksimalt 7,5 ml pr. dosis 
10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.2 mL/kg body weight twice daily with a maximum of 7.5 mL per dose
10 mg/kg op til 15 mg/kg legemsvægt to gange dagligt, maksimalt 500 mg pr. dosis, svarende til 0,2 ml/kg legemsvægt to gange dagligt til 0,3 ml/kg legemsvægt to gange dagligt, maksimalt 10 ml pr. dosis 
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.2 mL/kg body weight twice daily to 0.3 mL/kg body weight twice daily with a maximum of 10 mL per dose
10 mg/kg op til 15 mg/kg legemsvægt to gange dagligt, maksimalt 500 mg pr. dosis, svarende til 0,1 ml/kg legemsvægt to gange dagligt til 0,15 ml/kg legemsvægt to gange dagligt, maksimalt 5 ml pr. dosis 
10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose, corresponding to a 0.1 mL/kg body weight twice daily to 0.15 mL/kg body weight twice daily with a maximum of 5 mL per dose
Ciprofloxacin Bayer og tilhørende navne (se bilag I) 100 mg/ml granulat og solvens til oral suspension [Se bilag I - Udfyldes nationalt] 
Ciprofloxacin Bayer and associated names (see Annex I) 100 mg/mL granules and solvent for oral suspension [See Annex I - To be completed nationally]
CIPROXIN XR 1000 mg tabletter med modificeret udløsning oral anvendelse 
CIPROXIN XR 1000 mg modified release tablets oral use
NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN [Se bilag I - Udfyldes nationalt] {Navn og adresse} <{Tlf}> <{Fax}> <{Email}> 
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] {Name and Address} <{tel}> <{fax}> <{e-mail}>
Ciproxina OD 1000 mg tabletter med modificeret udløsning oral anvendelse 
Ciproxina OD 1000 mg modified release tablets oral use
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE KARTON (indeholder beskyttelsesposer med poser med 200 ml infusionsvæske, opløsning) 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (containing wraps with bags of 200 mL solution for infusion)
10 ml to gange dagligt op til 15 ml to gange dagligt (to 5 ml måleskeer to gange dagligt op til tre 5 ml måleskeer to gange dagligt) 
10 mL twice daily to 15 mL twice daily (two 5-mL measuring spoonfuls twice daily up to three 5-mL measuring spoonfuls twice daily)
CIPROXIN 500 mg filmovertrukne tabletter oral anvendelse 
CIPROXIN 500 mg film-coated tablets oral use
250 mg/5 ml suspension oral anvendelse 
250 mg/5 ml oral suspension oral use
luftafgang fra tarmen - leversygdomme, øget mængde af et stof i blodet (bilirubin), gulsot (cholestatisk icterus) - udslæt, kløe eller nældefeber - ledsmerter hos voksne - nedsat nyrefunktion, nyresvigt - smerter i muskler og knogler, almen utilpashed (asteni), feber, væskeophobning - øget mængde af et bestemt stof i blodet (basisk fosfatase) 
(cholestatic icterus) - itching, hives - joint pain in adults - poor kidney function, kidney failure - pains in your muscles and bones, feeling unwell (asthenia), fever, fluid retention - increase in blood alkaline phosphatase (a certain substance in the blood)
Ciprofloxacin Bayer 750 mg filmovertrukne tabletter er indiceret til behandling af følgende infektioner (se pkt. 
Ciprofloxacin Bayer 750 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1).
Ciprofloxacin Bayer og tilhørende navne (se bilag I) 50 mg/ml granulat og solvens til oral suspension [Se bilag I - Udfyldes nationalt] 
Ciprofloxacin Bayer and associated names (see Annex I) 50 mg/mL granules and solvent for oral suspension [See Annex I - To be completed nationally]
10 ml to gange dagligt (to 5 ml måleskeer to gange dagligt) 
10 mL twice daily (two 5-mL measuring spoonfuls twice daily)
2 Vær ekstra forsigtig med Ciprofloxacin Bayer) - nedsat hudfølsomhed, rysten, migræne, lugteforstyrrelser (olfaktorisk sygdom), øresusen (tinnitus), nedsat hørelse - besvimelse, betændelse i blodårene (vasculitis) - åndenød, herunder astmasymptomer - bugspytkirtelbetændelse (pancreatitis) - leverbetændelse (hepatitis), døde leverceller (levernekrose), som meget sjældent kan føre til livstruende leversvigt - lysfølsomhed (se pkt. 
Section 2: Take special care with Ciprofloxacin Bayer) - decreased skin sensitivity, tremor, migraine, disorder of sense of smell (olfactory disorders) - tinnitus, impaired hearing - fainting, inflammation of the blood vessel (vasculitis) - shortness of breath including asthmatic symptoms - pancreatitis - hepatitis, death of liver cells (liver necrosis) very rarely leading to life-threatening liver failure - sensitivity to light (see Section 2: Take special care with Ciprofloxacin Bayer), small, pin-point bleeding under the skin (petechiae)
krampeanfald (se pkt 2 Vær ekstra forsigtig med at tage Ciprofloxacin Bayer) eller svimmelhed - synsforstyrrelser - øresusen (tinnitus) eller tab af hørelse - hurtige hjerteslag (takykardi) - udvidelse af blodkarrene (vasodilation), lavt blodtryk eller besvimelse - åndenød, herunder astmasymptomer - leversygdom, gulsot (cholestatisk icterus) eller ikke-smitsom leverbetændelse - lysfølsomhed (se pkt. 
seizures (see Section 2: Take special care with Ciprofloxacin Bayer), or giddiness - eyesight problems - tinnitus, loss of hearing, impaired hearing - rapid heartbeat (tachycardia) - expansion of blood vessels (vasodilation), low blood pressure, or fainting - shortness of breath, including asthmatic symptoms - liver disorders, jaundice (cholestatic icterus), or hepatitis - sensitivity to light (see Section 2: Take special care with Ciprofloxacin Bayer) - muscle pain, inflammation of the joints, increased muscle tone, or cramp - kidney failure, blood or crystals in the urine (see Section 2: Take special care with
Ciprofloxacin Bayer 250 mg filmovertrukne tabletter er indiceret til behandling af følgende infektioner (se pkt. 
Ciprofloxacin Bayer 250 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1).
YDERLIGERE OPLYSNINGER Ciprofloxacin Bayer indeholder: [Udfyldes nationalt] Udseende og pakningstørrelser Infusionsvæske, opløsning [Udfyldes nationalt] 
What Ciprofloxacin Bayer looks like and contents of the pack Solution for infusion [To be completed nationally]
500 mg/5 ml suspension oral anvendelse 
500 mg/5 ml oral suspension oral use
• Urethritis og cervicitis forårsaget af gonokokker 
• Gonococcal uretritis and cervicitis
Du må ikke tage Ciprofloxacin Bayer, hvis du er gravid. 
Do not take Ciprofloxacin Bayer if you are:
Ciprofloxacin Bayer 200 mg/100 ml infusionsvæske, opløsning er indiceret til behandling af følgende infektioner (se pkt. 
Ciprofloxacin Bayer 200 mg/100 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1).
Ciprobay XR 500 mg tabletter med modificeret udløsning oral anvendelse 
Ciprobay XR 500 mg modified release tablets oral use
Belgien 
Belgium:
5 ml to gange dagligt (én 5 ml måleske to gange dagligt) 
5 mL twice daily (one 5-mL measuring spoonful twice daily)
MINDSTEKRAV TIL MÆRKNING DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER 
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SINGLE DOSE SACHETS 250 MG
SÅDAN SKAL DU TAGE CIPROFLOXACIN BAYER 
HOW TO TAKE CIPROFLOXACIN BAYER
Du må dog ikke tage Ciprofloxacin Bayertabletterne sammen med mælkeprodukter, som f.eks. mælk eller yoghurt, eller sammen med beriget frugtjuice (f.eks. calciumberiget orangejuice). 
However, do not take Ciprofloxacin Bayer tablets with dairy products such as milk or yoghurt or with fortified fruit-juices (e.g. calcium-fortified orange juice).
- hvis du tager tizanidin (se pkt. 
• taking tizanidine (see Section 2: Taking other medicines)
Ciproxina OD 500 mg tabletter med modificeret udløsning oral anvendelse 
Ciproxina OD 500 mg modified release tablets oral use
Gastrointestinale og intraabdorminale infektioner 
• gastro-intestinal tract infections and intra-abdominal infections
CIPROXIN 1000 mg tabletter med modificeret udløsning oral anvendelse 
CIPROXIN 1000 mg modified release tablets oral use
• Akut exacerbation af kronisk sinusitis, især hvis infektionerne skyldes gramnegative bakterier, herunder Pseudomonas aeruginosa 
• Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
250 mg filmovertrukne tabletter oral anvendelse 
250 mg film-coated tablets oral use
CIPROBAY 400 mg/200 ml infusionsvæske, opløsning intravenøs anvendelse 2 mg/ml 
CIPROBAY 400 mg/200 ml solution for infusion intravenous use
Den behandlende læge skal rådføre sig med nationale og/eller internationale konsensusdokumenter vedrørende behandling af miltbrand. 
The treating physician should refer to national and/or international consensus documents regarding treatment of anthrax.
Hvis din behandling med Ciprofloxacin Bayer stoppes 
If you stop your course of Ciprofloxacin Bayer
Spørg din læge eller apotek til råds, før du tager nogen form for medicin. 
Ask your pharmacist how to dispose of any medicines no longer required.
CIPROBAY 200 mg/100 ml infusionsvæske, opløsning intravenøs anvendelse 2 mg/ml 
CIPROBAY 200 mg/100 ml solution for infusion intravenous use
Tubulointerstitiel nephritis 
Renal failure Haematuria Crystalluria (see section 4.4) Tubulointerstitial nephritis
Ciprofloxacin Bayer og tilhørende navne (se bilag I) 750 mg filmovertrukne tabletter [Se bilag I - Udfyldes nationalt] 
Ciprofloxacin Bayer and associated names (see Annex I) 750 mg film-coated tablets [See Annex I - To be completed nationally]
CIPROXIN 400 mg/200 ml infusionsvæske, opløsning intravenøs anvendelse 2 mg / ml 
CIPROXIN 400 mg/200 ml solution for infusion intravenous use
Nerve 
Neutropenia
CIPROXIN 200 mg/100 ml infusionsvæske, opløsning intravenøs anvendelse 2 mg / ml 
CIPROXIN 200 mg/100 ml solution for infusion intravenous use
750 mg filmovertrukne tabletter oral anvendelse 
750 mg film-coated tablets oral use
20 mg/kg legemsvægt to gange dagligt, maksimalt 750 mg pr. dosis, svarende til 0,2 ml/kg legemsvægt to gange dagligt, maksimalt 7,5 ml pr. dosis 
20 mg/kg body weight twice daily with a maximum of 750 mg per dose, corresponding to a 0.2 mL/kg body weight twice daily with a maximum of 7.5 mL per dose
CIPROXIN 500 mg tabletter med modificeret udløsning oral anvendelse 
CIPROXIN 500 mg modified release tablets oral use
Bayer HealthCare AG D-51368 Leverkusen, Tyskland 
Bayer Healthcare AG D-51368 Leverkusen, Germany